From 2024 to 2028, the forecast for musculo-skeletal system medicine sales in Germany shows a consistent decrease in total sales by year, starting from 2.5 in 2024 and dropping to 2.1 by 2028. This represents a steady decline year-over-year. The compound annual growth rate (CAGR) reflects this downtrend over the five-year period, suggesting a possible shift in market dynamics or adjustments in demand patterns.

Future trends to watch for include:

Potential innovations in non-pharmaceutical treatments or alternative therapies that might affect sales.
Adjustments in healthcare policies that impact pricing and reimbursement.
Demographic shifts influencing the prevalence and treatment of musculo-skeletal conditions.